Based on the key measurements obtained from SpectrumDNA's financial statements, SpectrumDNA is not in a good financial situation at this time. It has a very high risk of going through financial distress in March. At present, SpectrumDNA's Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 186.8 K, whereas Retained Earnings are forecasted to decline to (8.5 M).
Cash Flow Balance Sheet Income Statement
Credit Downgrade
Yuan Drop
Covid
Interest Hikes
SpectrumDNA Balance Sheet Chart
At present, SpectrumDNA's Total Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 186.8 K, whereas Retained Earnings are forecasted to decline to (8.5 M).
The essential information of the day-to-day investment outlook for SpectrumDNA includes many different criteria found on its balance sheet. An individual investor should research SpectrumDNA's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in SpectrumDNA.
Please note, the presentation of SpectrumDNA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, SpectrumDNA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of SpectrumDNA's management manipulating its earnings.
SpectrumDNA Stock Summary
Spectrum DNA, Inc. operates a social media studio that creates digital networked applications, which are engines of engagement primarily for media outlets and brand advertisers. The company was founded in 2006 and is based in Park City, Utah. Spectrumdna operates under Internet Information Providers classification in the United States and is traded on OTC Exchange. It employs 8 people.
Comparative valuation techniques use various fundamental indicators to help in determining SpectrumDNA's current stock value. Our valuation model uses many indicators to compare SpectrumDNA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SpectrumDNA competition to find correlations between indicators driving SpectrumDNA's intrinsic value. More Info.
SpectrumDNA is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At present, SpectrumDNA's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SpectrumDNA's earnings, one of the primary drivers of an investment's value.
Most indicators from SpectrumDNA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into SpectrumDNA current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SpectrumDNA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.
What exactly are SpectrumDNA Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include SpectrumDNA's income statement, its balance sheet, and the statement of cash flows. Potential SpectrumDNA investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although SpectrumDNA investors may use each financial statement separately, they are all related. The changes in SpectrumDNA's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on SpectrumDNA's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Complementary Tools for SpectrumDNA Stock analysis
When running SpectrumDNA's price analysis, check to measure SpectrumDNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpectrumDNA is operating at the current time. Most of SpectrumDNA's value examination focuses on studying past and present price action to predict the probability of SpectrumDNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpectrumDNA's price. Additionally, you may evaluate how the addition of SpectrumDNA to your portfolios can decrease your overall portfolio volatility.